Cargando…
Pharmacogenomics arrives
We've had the human genome sequence for a little while now, and it looks as though we're still some way off being able to exclude from most clinical trials those people who will probably suffer side effects.
| Autor principal: | |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2004
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC463047/ https://www.ncbi.nlm.nih.gov/pubmed/15186481 http://dx.doi.org/10.1186/gb-2004-5-6-108 |